NCT05484622 2026-03-12Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaServierPhase 1 Active not recruiting60 enrolled
NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled
NCT02381886 2025-11-10A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNovartisPhase 1 Active not recruiting166 enrolled
NCT05561374 2024-11-29Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaOblato, Inc.Phase 1 Active not recruiting16 enrolled